Drug Discovery unbound

Propelled by our novel ACEAT™ technology, Xomics is charting towards a blue ocean of opportunities to develop protein therapeutics targeting complex membrane-bound proteins, which account for nearly 40% of the druggable human genome.   

Please contact us for more information.

1400 Bridge Pkwy, Suite 202, Redwood City, CA 94065